Thrombocytopenia associated with levodopa treatment

Archives of Internal Medicine

Volumn 163, Issue 6, 2003, Pages 735-736

  Giner, Vicente ^a   Rueda, Diego ^b   Salvador, Antonio ^b   Hernández, Juan Carlos ^b   Esteban, María José ^b   Redón, Josep ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BENSERAZIDE PLUS LEVODOPA; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; DIGOXIN; GOLD SALT; PREDNISONE; QUINIDINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

AGED; ANAMNESIS; ARTICLE; AUTOIMMUNITY; BLEEDING; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG RESPONSE; HEART FAILURE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT FAILURE;

AGED; ANTIPARKINSON AGENTS; BLOOD PLATELETS; DOPAMINE AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; LEVODOPA; MALE; PLATELET COUNT; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0037463860     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.6.735     Document Type: Article

References (6)

1. Kaufman DW, Kelly JP, Johannes CB, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood. 1993;82:2714-18.
2. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998;129:886-890.
3. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1998;79:1-7.
4. Aster RH. Drug-induced immune thrombocytopenia: An overview of pathogenesis. Semin Hematol. 1999;36(suppl 1):2-6.
5. Wanamaker WM, Wanamaker SJ, Celesia GG, Koeller AA. Thrombocytopenia associated with long-term levodopa therapy. JAMA. 1976;235:2217-2219.
6. The American Society of Hematology 1TP Practice Guideline Panel. Diagnosis and treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology. Ann Intern Med. 1997;126:319-326.